Articles
Considering LC-MS/MS for therapeutic drug monitoring?
We take a look at the top four pitfalls to avoid when implementing LC-MS/MS for immunosuppressant drug monitoring. [ + ]
Govt pledges $66m for COVID-19 research — but will it save the sector?
The Australian Government has announced further funding for research into COVID-19 — but is the biotech community being left behind? [ + ]
Fermented foods are strongly linked to the gut microbiome
Fermented foods can be a primary source of potentially probiotic lactic acid bacteria (LAB) for the human gut, as shown in an international study. [ + ]
More effective human antibodies made from chicken cells
Antibodies for potential use as medicines can be made rapidly in chicken cells grown in laboratories. [ + ]
Promising results for first human trial of COVID-19 vaccine
The first COVID-19 vaccine to reach phase 1 clinical trial was deemed safe, well tolerated and able to generate an immune response against SARS-CoV-2 in humans. [ + ]
Aus STEM workforce feels the blow of COVID‑19
Australia's research workforce will be severely impacted by the COVID-19 pandemic for an extended period, according to a newly published report. [ + ]
Boosting immunotherapy for more effective cancer treatment
Activating two different types of immune cells at the same time can boost the effects of immunotherapy to find and kill cancer cells in solid tumours. [ + ]
Plants control their own microbiome diversity
New research has revealed how plants use their genes to select which microbes get to live inside their leaves in order to stay healthy. [ + ]
Reduced need for blood transfusions in thalassemia patients
A new medication is reducing the need for blood transfusions in thalassemia patients and improving bone-marrow transplant outcomes. [ + ]
Diagnostic test tracks the spread of infectious diseases
The new diagnostic approach has the potential to enhance infectious diseases surveillance, and so is now being adapted to track immunity to COVID-19. [ + ]
How does the microbiome contribute to liver disease?
UK researchers have revealed how interactions between gut microbes and cells of the immune system contribute to cholestatic liver disease. [ + ]
3D imaging tech makes fluorescence microscopy more efficient
Hong Kong researchers have developed a new optical imaging technology that they believe will push the boundaries of living cells research. [ + ]
TB vaccine trial for COVID-19 goes international
The BCG tuberculosis vaccine, now being tested against COVID-19, is being expanded to 10,000 healthcare workers across Australia, Spain and the Netherlands. [ + ]
Fighting the COVID-19 fire with molecular diagnostics innovations
Unlike in the influenza pandemic in 1918, today we are better equipped to identify the elusive bug responsible for COVID-19. [ + ]
AI helps optimise drug therapies for infectious diseases
Researchers are harnessing the power of artificial intelligence in an attempt to dramatically accelerate the discovery of drug combination therapies. [ + ]